MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC

Position in JNJ — Johnson & Johnson

CIK 1015877 ORLEANS, MA

Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,260,079

-$665,867 QoQ

Shares Held

8,899

-25.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.76%

of 13F equity value

Holder Rank

#2,247

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC holds $3,410,790 across 4 Drug Manufacturers - General names. JNJ ranks #1 (66.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	8,899	$2,260,079
2	AMGN	Amgen Inc	1,557	$563,820
3	LLY	ELI LILLY & Co	262	$314,250
4	GILD	Gilead Sciences, Inc.	2,158	$272,641

All Filings in JNJ

Export CSV

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,260,079	8,899	-25.7%	Shares	Sole	2026-08-12
2026-03-31	$2,925,946	11,970	0.0%	Shares	Sole	2026-05-13
2025-12-31	$2,477,191	11,970	-8.1%	Shares	Sole	2026-02-12
2025-09-30	$2,415,280	13,026	+7.4%	Shares	Sole	2025-11-13
2025-06-30	$1,852,857	12,130	+0.0%	Shares	Sole	2025-08-11
2025-03-31	$2,011,473	12,129	+1.5%	Shares	Sole	2025-05-08
2024-12-31	$1,727,919	11,948	-2.0%	Shares	Sole	2025-02-07
2024-09-30	$1,975,835	12,192	-0.8%	Shares	Sole	2024-11-12
2024-06-30	$1,796,452	12,291	+0.8%	Shares	Sole	2024-08-08
2024-03-31	$1,928,652	12,192	+9.1%	Shares	Sole	2024-04-30
2023-12-31	$1,751,099	11,172	+0.0%	Shares	Sole	2024-02-14
2023-09-30	$1,739,883	11,171	-29.4%	Shares	Sole	2023-11-08
2023-06-30	$2,619,022	15,823	-5.9%	Shares	Sole	2023-08-14
2023-03-31	$2,607,410	16,822	+0.3%	Shares	Sole	2023-05-10
2022-12-31	$2,962,773	16,772	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.